// App-Quantinova.ai

11527 : Androgen receptor activation in HER2-negative breast cancer liver metastases.

Researchers

Presenter

  • Corinne Ramos

Principal Investigators

  • Mariaelena Pierobon

  • Nicholas N Hoke

  • Lance A. Liotta

  • Ahmad Abdelfattah Al-Hader

  • Maren K Levin

  • Bryant Dunetz

  • Emanuel Petricoin

  • Joyce O'Shaughnessy

Medical Centers

  • Theranostics Health, Inc., Rockville, MD

  • George Mason University, Manassas, VA

  • Baylor University Medical Center, Dallas, TX

  • The Side-Out Foundation, Fairfax, VA

  • Baylor University Medical Center, Texas Oncology, Dallas, TX

Locations

  • United States

Companies

  • Theranostics Health,

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Secondary liver cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Androgen receptor

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final